Rani Therapeutics Correlations

RANI Stock  USD 1.99  0.04  2.05%   
The current 90-days correlation between Rani Therapeutics and Ikena Oncology is 0.07 (i.e., Significant diversification). The correlation of Rani Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Rani Therapeutics Correlation With Market

Modest diversification

The correlation between Rani Therapeutics Holdings and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rani Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Rani Stock

  0.68MREO Mereo BioPharma GroupPairCorr
  0.66ACRV Acrivon Therapeutics,PairCorr
  0.66AFMD Affimed NVPairCorr

Moving against Rani Stock

  0.52MNOV MediciNovaPairCorr
  0.4BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.42ACIU AC ImmunePairCorr
  0.38CRVS Corvus PharmaceuticalsPairCorr
  0.32AVTE Aerovate TherapeuticsPairCorr
  0.31VREX Varex Imaging CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SCPHELYM
TPSTELYM
MCRBELYM
SCPHTPST
MISTRNXT
MCRBSCPH
  
High negative correlations   
LUMOTPST
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTSCPH
MISTELYM

Risk-Adjusted Indicators

There is a big difference between Rani Stock performing well and Rani Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rani Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Rani Therapeutics Corporate Management

Alireza JavadiVice OperationsProfile
Svai SanfordChief OfficerProfile
Mir HashimChief OfficerProfile
Arvinder DhallaVice DevelopmentProfile
Bella VazquezVice ResourcesProfile
Eric GroenGeneral CounselProfile
Kate MBAChief OfficerProfile